Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

Five patients with acute myelogenous leukemia received hematopoietic stem-cell transplants from a haploidentical donor. They also received T cells from the donor. All five patients had a relapse, and at the time of relapse, genomic HLA typing of leukemic blasts could not detect the recipient's...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:The New England journal of medicine Ročník 361; číslo 5; s. 478 - 488
Hlavní autori: Vago, Luca, Perna, Serena Kimi, Zanussi, Monica, Mazzi, Benedetta, Barlassina, Cristina, Stanghellini, Maria Teresa Lupo, Perrelli, Nicola Flavio, Cosentino, Cristian, Torri, Federica, Angius, Andrea, Forno, Barbara, Casucci, Monica, Bernardi, Massimo, Peccatori, Jacopo, Corti, Consuelo, Bondanza, Attilio, Ferrari, Maurizio, Rossini, Silvano, Roncarolo, Maria Grazia, Bordignon, Claudio, Bonini, Chiara, Ciceri, Fabio, Fleischhauer, Katharina
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Waltham, MA Massachusetts Medical Society 30.07.2009
Predmet:
ISSN:0028-4793, 1533-4406, 1533-4406
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Five patients with acute myelogenous leukemia received hematopoietic stem-cell transplants from a haploidentical donor. They also received T cells from the donor. All five patients had a relapse, and at the time of relapse, genomic HLA typing of leukemic blasts could not detect the recipient's HLA haplotype that differed from the donor's. The loss of the haplotype was due to uniparental disomy. In vitro, the donor's T cells reacted against leukemic blasts obtained at the time of diagnosis, not against blasts obtained at relapse. The results indicate the presence of a mutation that allowed the leukemic cells to escape the immunosurveillance of the donor's T cells. Five patients with acute myelogenous leukemia received hematopoietic stem-cell transplants from a haploidentical donor. They also received T cells from the donor. All five patients had a relapse, and at the time of relapse, genomic HLA typing of leukemic blasts could not detect the recipient's HLA haplotype that differed from the donor's. Transplantation of hematopoietic stem cells from a haploidentical family donor who shares only one HLA haplotype with the recipient is a potentially curative option for patients with high-risk hematologic cancers who lack an HLA-matched donor. 1 – 3 The major limitation of this strategy is the risk of severe graft-versus-host disease (GVHD), which can result from alloreactions mediated by donor T cells against the recipient's unshared HLA haplotype. Since the publication of studies on extensively T-cell–depleted grafts, 1 , 2 a variety of strategies have been developed to prevent or control GVHD after transfer of haploidentical T cells. 4 , 5 The feasibility and efficacy of . . .
AbstractList Five patients with acute myelogenous leukemia received hematopoietic stem-cell transplants from a haploidentical donor. They also received T cells from the donor. All five patients had a relapse, and at the time of relapse, genomic HLA typing of leukemic blasts could not detect the recipient's HLA haplotype that differed from the donor's. The loss of the haplotype was due to uniparental disomy. In vitro, the donor's T cells reacted against leukemic blasts obtained at the time of diagnosis, not against blasts obtained at relapse. The results indicate the presence of a mutation that allowed the leukemic cells to escape the immunosurveillance of the donor's T cells. Five patients with acute myelogenous leukemia received hematopoietic stem-cell transplants from a haploidentical donor. They also received T cells from the donor. All five patients had a relapse, and at the time of relapse, genomic HLA typing of leukemic blasts could not detect the recipient's HLA haplotype that differed from the donor's. Transplantation of hematopoietic stem cells from a haploidentical family donor who shares only one HLA haplotype with the recipient is a potentially curative option for patients with high-risk hematologic cancers who lack an HLA-matched donor. 1 – 3 The major limitation of this strategy is the risk of severe graft-versus-host disease (GVHD), which can result from alloreactions mediated by donor T cells against the recipient's unshared HLA haplotype. Since the publication of studies on extensively T-cell–depleted grafts, 1 , 2 a variety of strategies have been developed to prevent or control GVHD after transfer of haploidentical T cells. 4 , 5 The feasibility and efficacy of . . .
Transplantation of hematopoietic stem cells from partially matched family donors is a promising therapy for patients who have a hematologic cancer and are at high risk for relapse. The donor T-cell infusions associated with such transplantation can promote post-transplantation immune reconstitution and control residual disease.BACKGROUNDTransplantation of hematopoietic stem cells from partially matched family donors is a promising therapy for patients who have a hematologic cancer and are at high risk for relapse. The donor T-cell infusions associated with such transplantation can promote post-transplantation immune reconstitution and control residual disease.We identified 43 patients who underwent haploidentical transplantation and infusion of donor T cells for acute myeloid leukemia or myelodysplastic syndrome and conducted post-transplantation studies that included morphologic examination of bone marrow, assessment of hematopoietic chimerism with the use of short-tandem-repeat amplification, and HLA typing. The genomic rearrangements in mutant variants of leukemia were studied with the use of genomic HLA typing, microsatellite mapping, and single-nucleotide-polymorphism arrays. The post-transplantation immune responses against the original cells and the mutated leukemic cells were analyzed with the use of mixed lymphocyte cultures.METHODSWe identified 43 patients who underwent haploidentical transplantation and infusion of donor T cells for acute myeloid leukemia or myelodysplastic syndrome and conducted post-transplantation studies that included morphologic examination of bone marrow, assessment of hematopoietic chimerism with the use of short-tandem-repeat amplification, and HLA typing. The genomic rearrangements in mutant variants of leukemia were studied with the use of genomic HLA typing, microsatellite mapping, and single-nucleotide-polymorphism arrays. The post-transplantation immune responses against the original cells and the mutated leukemic cells were analyzed with the use of mixed lymphocyte cultures.In 5 of 17 patients with leukemia relapse after haploidentical transplantation and infusion of donor T cells, we identified mutant variants of the original leukemic cells. In the mutant leukemic cells, the HLA haplotype that differed from the donor's haplotype had been lost because of acquired uniparental disomy of chromosome 6p. T cells from the donor and the patient after transplantation did not recognize the mutant leukemic cells, whereas the original leukemic cells taken at the time of diagnosis were efficiently recognized and killed.RESULTSIn 5 of 17 patients with leukemia relapse after haploidentical transplantation and infusion of donor T cells, we identified mutant variants of the original leukemic cells. In the mutant leukemic cells, the HLA haplotype that differed from the donor's haplotype had been lost because of acquired uniparental disomy of chromosome 6p. T cells from the donor and the patient after transplantation did not recognize the mutant leukemic cells, whereas the original leukemic cells taken at the time of diagnosis were efficiently recognized and killed.After transplantation of haploidentical hematopoietic stem cells and infusion of donor T cells, leukemic cells can escape from the donor's antileukemic T cells through the loss of the mismatched HLA haplotype. This event leads to relapse.CONCLUSIONSAfter transplantation of haploidentical hematopoietic stem cells and infusion of donor T cells, leukemic cells can escape from the donor's antileukemic T cells through the loss of the mismatched HLA haplotype. This event leads to relapse.
Background Transplantation of hematopoietic stem cells from partially matched family donors is a promising therapy for patients who have a hematologic cancer and are at high risk for relapse. The donor T-cell infusions associated with such transplantation can promote post-transplantation immune reconstitution and control residual disease. Methods We identified 43 patients who underwent haploidentical transplantation and infusion of donor T cells for acute myeloid leukemia or myelodysplastic syndrome and conducted post-transplantation studies that included morphologic examination of bone marrow, assessment of hematopoietic chimerism with the use of short-tandem-repeat amplification, and HLA typing. The genomic rearrangements in mutant variants of leukemia were studied with the use of genomic HLA typing, microsatellite mapping, and single-nucleotide-polymorphism arrays. The post-transplantation immune responses against the original cells and the mutated leukemic cells were analyzed with the use of mixed lymphocyte cultures. Results In 5 of 17 patients with leukemia relapse after haploidentical transplantation and infusion of donor T cells, we identified mutant variants of the original leukemic cells. In the mutant leukemic cells, the HLA haplotype that differed from the donor's haplotype had been lost because of acquired uniparental disomy of chromosome 6p. T cells from the donor and the patient after transplantation did not recognize the mutant leukemic cells, whereas the original leukemic cells taken at the time of diagnosis were efficiently recognized and killed. Conclusions After transplantation of haploidentical hematopoietic stem cells and infusion of donor T cells, leukemic cells can escape from the donor's antileukemic T cells through the loss of the mismatched HLA haplotype. This event leads to relapse.
Transplantation of hematopoietic stem cells from partially matched family donors is a promising therapy for patients who have a hematologic cancer and are at high risk for relapse. The donor T-cell infusions associated with such transplantation can promote post-transplantation immune reconstitution and control residual disease. We identified 43 patients who underwent haploidentical transplantation and infusion of donor T cells for acute myeloid leukemia or myelodysplastic syndrome and conducted post-transplantation studies that included morphologic examination of bone marrow, assessment of hematopoietic chimerism with the use of short-tandem-repeat amplification, and HLA typing. The genomic rearrangements in mutant variants of leukemia were studied with the use of genomic HLA typing, microsatellite mapping, and single-nucleotide-polymorphism arrays. The post-transplantation immune responses against the original cells and the mutated leukemic cells were analyzed with the use of mixed lymphocyte cultures. In 5 of 17 patients with leukemia relapse after haploidentical transplantation and infusion of donor T cells, we identified mutant variants of the original leukemic cells. In the mutant leukemic cells, the HLA haplotype that differed from the donor's haplotype had been lost because of acquired uniparental disomy of chromosome 6p. T cells from the donor and the patient after transplantation did not recognize the mutant leukemic cells, whereas the original leukemic cells taken at the time of diagnosis were efficiently recognized and killed. After transplantation of haploidentical hematopoietic stem cells and infusion of donor T cells, leukemic cells can escape from the donor's antileukemic T cells through the loss of the mismatched HLA haplotype. This event leads to relapse.
Author Cosentino, Cristian
Casucci, Monica
Bordignon, Claudio
Ciceri, Fabio
Perrelli, Nicola Flavio
Bernardi, Massimo
Forno, Barbara
Peccatori, Jacopo
Stanghellini, Maria Teresa Lupo
Vago, Luca
Angius, Andrea
Zanussi, Monica
Mazzi, Benedetta
Roncarolo, Maria Grazia
Rossini, Silvano
Bonini, Chiara
Perna, Serena Kimi
Bondanza, Attilio
Barlassina, Cristina
Torri, Federica
Corti, Consuelo
Ferrari, Maurizio
Fleischhauer, Katharina
Author_xml – sequence: 1
  givenname: Luca
  surname: Vago
  fullname: Vago, Luca
– sequence: 2
  givenname: Serena Kimi
  surname: Perna
  fullname: Perna, Serena Kimi
– sequence: 3
  givenname: Monica
  surname: Zanussi
  fullname: Zanussi, Monica
– sequence: 4
  givenname: Benedetta
  surname: Mazzi
  fullname: Mazzi, Benedetta
– sequence: 5
  givenname: Cristina
  surname: Barlassina
  fullname: Barlassina, Cristina
– sequence: 6
  givenname: Maria Teresa Lupo
  surname: Stanghellini
  fullname: Stanghellini, Maria Teresa Lupo
– sequence: 7
  givenname: Nicola Flavio
  surname: Perrelli
  fullname: Perrelli, Nicola Flavio
– sequence: 8
  givenname: Cristian
  surname: Cosentino
  fullname: Cosentino, Cristian
– sequence: 9
  givenname: Federica
  surname: Torri
  fullname: Torri, Federica
– sequence: 10
  givenname: Andrea
  surname: Angius
  fullname: Angius, Andrea
– sequence: 11
  givenname: Barbara
  surname: Forno
  fullname: Forno, Barbara
– sequence: 12
  givenname: Monica
  surname: Casucci
  fullname: Casucci, Monica
– sequence: 13
  givenname: Massimo
  surname: Bernardi
  fullname: Bernardi, Massimo
– sequence: 14
  givenname: Jacopo
  surname: Peccatori
  fullname: Peccatori, Jacopo
– sequence: 15
  givenname: Consuelo
  surname: Corti
  fullname: Corti, Consuelo
– sequence: 16
  givenname: Attilio
  surname: Bondanza
  fullname: Bondanza, Attilio
– sequence: 17
  givenname: Maurizio
  surname: Ferrari
  fullname: Ferrari, Maurizio
– sequence: 18
  givenname: Silvano
  surname: Rossini
  fullname: Rossini, Silvano
– sequence: 19
  givenname: Maria Grazia
  surname: Roncarolo
  fullname: Roncarolo, Maria Grazia
– sequence: 20
  givenname: Claudio
  surname: Bordignon
  fullname: Bordignon, Claudio
– sequence: 21
  givenname: Chiara
  surname: Bonini
  fullname: Bonini, Chiara
– sequence: 22
  givenname: Fabio
  surname: Ciceri
  fullname: Ciceri, Fabio
– sequence: 23
  givenname: Katharina
  surname: Fleischhauer
  fullname: Fleischhauer, Katharina
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21804290$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19641204$$D View this record in MEDLINE/PubMed
BookMark eNp10U1P3DAQBmALUcFCe-RaRZXKLe34M8kRVhSoQnsoPUcTx1a9jZ2tnRz493W1C6hI2AdfHo_emTkhh2EKhpAzCp8oSPX529XXuwmhphS4OiArKjkvhQB1SFYArC5F1fBjcpLSBvKhojkix7RRgjIQK3LZTikVky3uXPI4619mKG7ai8KFojXLb-MdFmhnE4sfs_Hl2oxjcR8xpO2IYcbZTeEteWNxTObd_j0lP79c3a9vyvb79e36oi21ZDCXOcYgWU-hlkO-UlnKBEhRGdn3stdKa0RrZUWFwgGRM1tVolJGGlNr4PyUnO_qbuP0ZzFp7rxLOgfCYKYldaqSXAKlGX54ATfTEkPO1jHGG8pU02T0fo-W3puh20bnMT50j6PJ4OMeYNI42ty0dunJMVqDYA1kV-6cjnmU0djnUtD9W1H334qy5y-8drtBzhHd-OqvfRrvUxfMxr_i_gLunpx_
CODEN NEJMAG
CitedBy_id crossref_primary_10_1517_14712590903431022
crossref_primary_10_1111_ejh_12017
crossref_primary_10_1097_MPH_0000000000001443
crossref_primary_10_3389_fimmu_2020_01854
crossref_primary_10_1016_j_cellimm_2012_03_011
crossref_primary_10_3390_diseases10020033
crossref_primary_10_1038_s41409_021_01211_2
crossref_primary_10_1182_blood_2022019106
crossref_primary_10_1016_j_blre_2015_11_002
crossref_primary_10_1080_10428194_2020_1789630
crossref_primary_10_1002_cnr2_1519
crossref_primary_10_1002_JLB_5AB0820_542RR
crossref_primary_10_1182_blood_2012_04_427039
crossref_primary_10_1684_bdc_2014_1944
crossref_primary_10_1182_blood_2016_11_752378
crossref_primary_10_1007_s00262_009_0805_5
crossref_primary_10_1038_leu_2014_131
crossref_primary_10_1182_blood_2013_04_493361
crossref_primary_10_1155_2014_541345
crossref_primary_10_1016_j_coi_2014_01_010
crossref_primary_10_1158_2159_8290_CD_17_0343
crossref_primary_10_1097_MPH_0000000000000454
crossref_primary_10_1007_s11899_012_0145_y
crossref_primary_10_1186_s13073_018_0598_2
crossref_primary_10_1517_14712598_2011_573476
crossref_primary_10_3390_cancers13215319
crossref_primary_10_3389_fimmu_2024_1459175
crossref_primary_10_1093_jnci_djv439
crossref_primary_10_1007_s00277_020_04080_9
crossref_primary_10_1053_j_seminhematol_2022_08_004
crossref_primary_10_1038_s41409_022_01635_4
crossref_primary_10_3390_cancers15164137
crossref_primary_10_1016_j_bbmt_2017_10_023
crossref_primary_10_1016_j_exphem_2016_12_004
crossref_primary_10_1182_blood_2016_11_751065
crossref_primary_10_1158_2159_8290_CD_21_0980
crossref_primary_10_1038_s41409_017_0078_0
crossref_primary_10_1038_nrclinonc_2015_128
crossref_primary_10_1038_onc_2013_269
crossref_primary_10_1158_1078_0432_CCR_17_3016
crossref_primary_10_3389_fimmu_2021_642087
crossref_primary_10_3390_ph8020230
crossref_primary_10_3389_fimmu_2018_03136
crossref_primary_10_1111_ajt_17174
crossref_primary_10_1038_s41409_018_0244_z
crossref_primary_10_1038_s41568_025_00857_0
crossref_primary_10_3389_fimmu_2022_944872
crossref_primary_10_1182_bloodadvances_2017006429
crossref_primary_10_1007_s12185_021_03273_w
crossref_primary_10_1016_j_beha_2024_101561
crossref_primary_10_1097_MPH_0000000000000672
crossref_primary_10_1002_ajh_25750
crossref_primary_10_1182_blood_2010_11_314393
crossref_primary_10_1038_s41375_022_01619_9
crossref_primary_10_1182_bloodadvances_2024014460
crossref_primary_10_1080_10428194_2021_1984453
crossref_primary_10_1038_onc_2011_138
crossref_primary_10_1111_cas_16102
crossref_primary_10_1038_s41392_025_02269_w
crossref_primary_10_1111_tan_12830
crossref_primary_10_1016_j_pcl_2009_12_002
crossref_primary_10_1016_S2352_3026_24_00098_X
crossref_primary_10_1111_eva_12017
crossref_primary_10_1038_s41408_024_01060_4
crossref_primary_10_1016_j_trim_2012_09_002
crossref_primary_10_3389_fimmu_2022_1066748
crossref_primary_10_3389_fimmu_2024_1347492
crossref_primary_10_1038_s41409_022_01777_5
crossref_primary_10_1158_2159_8290_CD_22_0329
crossref_primary_10_1038_leu_2014_327
crossref_primary_10_1111_ejh_12322
crossref_primary_10_1007_s12185_024_03778_0
crossref_primary_10_1038_leu_2012_68
crossref_primary_10_1016_j_bbmt_2015_04_025
crossref_primary_10_1182_blood_2021014532
crossref_primary_10_1038_bmt_2016_324
crossref_primary_10_2147_CMAR_S261721
crossref_primary_10_3390_jcm12020646
crossref_primary_10_1016_j_exphem_2022_03_003
crossref_primary_10_1016_j_blre_2021_100829
crossref_primary_10_3389_fped_2023_1232281
crossref_primary_10_1182_bloodadvances_2017015230
crossref_primary_10_1097_TP_0b013e3182481113
crossref_primary_10_3389_fimmu_2024_1328858
crossref_primary_10_1002_jgm_2637
crossref_primary_10_1038_s41409_025_02622_1
crossref_primary_10_1016_j_molmed_2011_12_003
crossref_primary_10_1182_blood_2012_01_405670
crossref_primary_10_1038_s41408_019_0251_3
crossref_primary_10_1007_s00277_018_3482_7
crossref_primary_10_1080_17474086_2018_1459184
crossref_primary_10_1586_ehm_12_28
crossref_primary_10_1016_j_leukres_2010_09_016
crossref_primary_10_1177_20406207211043748
crossref_primary_10_1038_s41571_020_0356_4
crossref_primary_10_1016_j_bbmt_2012_09_020
crossref_primary_10_1016_j_bbmt_2017_07_014
crossref_primary_10_1177_2040620715616544
crossref_primary_10_1016_j_bbmt_2011_07_012
crossref_primary_10_1053_j_seminhematol_2016_01_010
crossref_primary_10_1111_tan_14372
crossref_primary_10_1016_j_beha_2010_06_002
crossref_primary_10_1038_s41586_023_06496_5
crossref_primary_10_1002_pbc_24962
crossref_primary_10_1016_j_jtct_2021_05_023
crossref_primary_10_1182_bloodadvances_2016002188
crossref_primary_10_1111_tan_70093
crossref_primary_10_1016_j_drup_2025_101286
crossref_primary_10_1158_2643_3230_BCD_25_0017
crossref_primary_10_1007_s00262_009_0809_1
crossref_primary_10_12998_wjcc_v11_i2_268
crossref_primary_10_1016_j_bbmt_2012_09_012
crossref_primary_10_1038_bmt_2014_116
crossref_primary_10_3389_fcell_2019_00207
crossref_primary_10_1016_j_humimm_2010_10_009
crossref_primary_10_1056_NEJMe0903177
crossref_primary_10_1016_j_ccell_2020_06_002
crossref_primary_10_1186_s12943_023_01889_6
crossref_primary_10_1182_blood_2024025705
crossref_primary_10_1016_j_ymthe_2017_06_029
crossref_primary_10_1586_ehm_10_32
crossref_primary_10_1097_PPO_0000000000000378
crossref_primary_10_1111_tan_12090
crossref_primary_10_3390_cancers16233974
crossref_primary_10_1111_trf_17189
crossref_primary_10_1097_TP_0b013e3182481154
crossref_primary_10_1056_NEJMoa1601202
crossref_primary_10_1016_j_hemonc_2021_03_001
crossref_primary_10_3389_fimmu_2024_1359113
crossref_primary_10_1056_NEJMoa1808777
crossref_primary_10_1097_MOH_0000000000000412
crossref_primary_10_1038_leu_2016_57
crossref_primary_10_1038_s41409_020_01081_0
crossref_primary_10_1016_j_humimm_2022_04_008
crossref_primary_10_1038_s41409_023_01985_7
crossref_primary_10_1111_tan_15472
crossref_primary_10_1097_MOH_0b013e32835822f5
crossref_primary_10_3389_fonc_2020_00697
crossref_primary_10_1093_emph_eoy011
crossref_primary_10_1038_bmt_2017_193
crossref_primary_10_1089_hum_2010_014
crossref_primary_10_1038_bmt_2015_91
crossref_primary_10_1182_blood_2021012411
crossref_primary_10_1182_blood_2021012895
crossref_primary_10_1038_bmt_2016_62
crossref_primary_10_1080_17474086_2020_1796621
crossref_primary_10_1016_j_clim_2010_11_015
crossref_primary_10_4049_jimmunol_2300111
crossref_primary_10_3390_ijms20092057
crossref_primary_10_1038_icb_2010_124
crossref_primary_10_1038_s41375_024_02268_w
crossref_primary_10_1158_2326_6066_CIR_15_0001
crossref_primary_10_1016_j_exphem_2020_09_189
crossref_primary_10_1146_annurev_med_051914_021702
crossref_primary_10_1097_PPO_0b013e3182341fde
crossref_primary_10_3389_fimmu_2015_00479
crossref_primary_10_1073_pnas_0904658106
crossref_primary_10_1038_bmt_2015_99
crossref_primary_10_1053_j_seminoncol_2012_09_009
crossref_primary_10_3109_14653241003786155
crossref_primary_10_1053_j_seminoncol_2012_09_006
crossref_primary_10_1016_j_coi_2017_11_003
crossref_primary_10_1053_j_seminoncol_2012_09_005
crossref_primary_10_1111_imr_12130
crossref_primary_10_1182_blood_2019000823
crossref_primary_10_1111_j_1399_0039_2012_01868_x
crossref_primary_10_3389_fphar_2014_00254
crossref_primary_10_1182_blood_2011_07_365189
crossref_primary_10_1111_tan_14167
crossref_primary_10_3390_jcm9010039
crossref_primary_10_1038_leu_2014_180
crossref_primary_10_1016_j_apsb_2020_06_012
crossref_primary_10_1016_j_bbmt_2017_09_009
crossref_primary_10_1016_j_leukres_2023_107038
crossref_primary_10_1111_bjh_19007
crossref_primary_10_3389_fimmu_2020_00147
crossref_primary_10_3389_fimmu_2022_999163
crossref_primary_10_1038_bmt_2016_167
crossref_primary_10_1038_s41409_021_01508_2
crossref_primary_10_1097_PPO_0000000000000575
crossref_primary_10_1038_bmt_2016_283
crossref_primary_10_3390_cancers16152615
crossref_primary_10_1002_cai2_72
crossref_primary_10_1007_s00277_020_04131_1
crossref_primary_10_1038_nature10738
crossref_primary_10_1182_blood_2022016082
crossref_primary_10_1182_bloodadvances_2016000943
crossref_primary_10_46989_001c_117961
crossref_primary_10_1038_s41591_019_0400_z
crossref_primary_10_3390_cancers12010069
crossref_primary_10_1111_ejh_13030
crossref_primary_10_1182_bloodadvances_2021004335
crossref_primary_10_1111_bjh_20215
crossref_primary_10_1038_pr_2011_60
crossref_primary_10_1111_bjh_19463
crossref_primary_10_1038_s41375_022_01723_w
crossref_primary_10_3389_fimmu_2022_1085978
crossref_primary_10_1080_10428194_2017_1306646
crossref_primary_10_1016_j_exphem_2024_104256
crossref_primary_10_1016_j_it_2017_04_004
crossref_primary_10_3390_cancers13153767
crossref_primary_10_1016_j_humimm_2019_02_009
crossref_primary_10_1038_s41409_017_0071_7
crossref_primary_10_1186_s40425_017_0211_z
crossref_primary_10_1111_j_1365_2249_2010_04197_x
crossref_primary_10_1515_sagmb_2020_0075
crossref_primary_10_1182_blood_2018_10_846824
crossref_primary_10_4049_jimmunol_1103710
crossref_primary_10_1016_S1773_035X_23_00085_0
crossref_primary_10_1080_14712598_2018_1384463
crossref_primary_10_1002_pbc_26839
crossref_primary_10_1016_j_humimm_2021_07_013
crossref_primary_10_1080_10428194_2020_1779255
crossref_primary_10_1084_jem_20092450
crossref_primary_10_3389_fimmu_2023_1290059
crossref_primary_10_3390_ijms241915019
crossref_primary_10_1038_s41416_020_0955_y
crossref_primary_10_1155_2011_303487
crossref_primary_10_1172_JCI129204
crossref_primary_10_1186_2051_1426_1_13
crossref_primary_10_3389_fimmu_2020_00191
crossref_primary_10_1016_j_bbmt_2011_02_013
crossref_primary_10_1182_bloodadvances_2019000445
crossref_primary_10_1016_j_bbmt_2015_02_003
crossref_primary_10_1016_j_blre_2018_12_001
crossref_primary_10_1172_JCI87366
crossref_primary_10_1136_jitc_2020_000734
crossref_primary_10_1200_JCO_2010_30_5813
crossref_primary_10_3389_fonc_2021_812207
crossref_primary_10_1016_j_bbmt_2018_01_031
crossref_primary_10_1016_j_clml_2025_08_013
crossref_primary_10_2217_imt_13_152
crossref_primary_10_1111_bjh_19304
crossref_primary_10_1182_bloodadvances_2020002945
crossref_primary_10_1182_blood_2011_07_365338
crossref_primary_10_1186_s13045_020_00882_6
crossref_primary_10_2217_imt_09_84
crossref_primary_10_1182_blood_2009_11_254284
crossref_primary_10_1158_2159_8290_CD_15_0439
crossref_primary_10_1093_labmed_lmac132
crossref_primary_10_1016_j_bulcan_2023_03_013
crossref_primary_10_1172_JCI177460
crossref_primary_10_1182_blood_2015_12_629089
crossref_primary_10_1016_S2352_3026_19_30158_9
crossref_primary_10_1111_tan_13005
crossref_primary_10_1136_jitc_2021_003392
crossref_primary_10_1056_NEJMe1612215
crossref_primary_10_1111_iji_12393
crossref_primary_10_3389_fimmu_2018_01819
crossref_primary_10_1053_j_seminoncol_2011_11_005
crossref_primary_10_2217_imt_2019_0215
crossref_primary_10_1182_bloodadvances_2022009493
crossref_primary_10_1016_j_humimm_2011_03_003
crossref_primary_10_1016_j_bbcan_2015_12_001
crossref_primary_10_1016_j_exphem_2017_11_001
crossref_primary_10_1111_bjh_18561
crossref_primary_10_1038_s41409_018_0171_z
crossref_primary_10_1016_j_jtct_2022_02_007
crossref_primary_10_3109_14653249_2010_530649
crossref_primary_10_1182_blood_2017_05_784306
crossref_primary_10_26508_lsa_201800079
crossref_primary_10_1016_j_jtct_2025_07_004
crossref_primary_10_1002_ajh_27471
crossref_primary_10_3390_life11020102
crossref_primary_10_1038_bmt_2014_285
crossref_primary_10_1080_16078454_2024_2347673
crossref_primary_10_1182_blood_2010_01_043737
crossref_primary_10_1038_s41409_020_0980_8
crossref_primary_10_1158_0008_5472_CAN_21_0301
crossref_primary_10_1038_mt_2012_227
crossref_primary_10_1016_j_clml_2013_05_006
crossref_primary_10_3389_fonc_2020_00262
crossref_primary_10_1016_j_cytogfr_2017_06_007
crossref_primary_10_1182_blood_2009_12_234096
crossref_primary_10_1016_j_bbmt_2019_01_016
crossref_primary_10_1158_2643_3230_BCD_24_0063
crossref_primary_10_1016_j_humimm_2022_03_001
crossref_primary_10_1038_s41467_019_08871_1
crossref_primary_10_1053_j_seminhematol_2015_04_002
crossref_primary_10_1016_j_bbmt_2010_08_001
crossref_primary_10_3389_fimmu_2021_695051
crossref_primary_10_1002_pbc_25819
crossref_primary_10_1111_petr_12267
crossref_primary_10_1038_leu_2010_133
crossref_primary_10_1080_14712598_2023_2174015
crossref_primary_10_3389_fonc_2022_787108
crossref_primary_10_1136_jitc_2020_000810
crossref_primary_10_3389_fped_2021_743294
crossref_primary_10_1038_s41409_021_01493_6
crossref_primary_10_1002_ijc_34243
crossref_primary_10_1007_s00262_022_03217_1
crossref_primary_10_1111_tan_13490
crossref_primary_10_1007_s11912_010_0113_4
crossref_primary_10_1053_j_seminhematol_2024_01_002
crossref_primary_10_1158_2159_8290_CD_20_1378
crossref_primary_10_1182_blood_2009_10_201848
crossref_primary_10_3390_cells12192392
crossref_primary_10_1038_s41375_021_01202_8
crossref_primary_10_1016_j_heliyon_2024_e39731
crossref_primary_10_1002_ajh_27175
crossref_primary_10_1111_bjh_16356
crossref_primary_10_1016_j_jmoldx_2017_01_005
crossref_primary_10_1038_leu_2010_189
crossref_primary_10_1111_bjh_16355
crossref_primary_10_1038_gt_2013_87
crossref_primary_10_1016_j_annonc_2021_08_2153
crossref_primary_10_1186_1752_1947_7_18
crossref_primary_10_3390_biomedicines12050975
crossref_primary_10_1002_acg2_77
crossref_primary_10_1182_blood_2025028617
crossref_primary_10_1053_j_seminhematol_2018_08_008
crossref_primary_10_1016_j_blre_2018_11_001
crossref_primary_10_1111_bjh_18529
crossref_primary_10_1016_j_beha_2011_04_002
crossref_primary_10_3389_fonc_2022_802648
crossref_primary_10_3390_cells11142249
crossref_primary_10_1038_s41598_024_51942_7
crossref_primary_10_1182_blood_2019001323
crossref_primary_10_1182_blood_2023019962
crossref_primary_10_1016_j_mrrev_2022_108445
crossref_primary_10_3389_fonc_2022_1066285
crossref_primary_10_1002_ajh_21628
crossref_primary_10_1038_s41409_019_0604_3
crossref_primary_10_3390_cancers13215390
crossref_primary_10_1038_s41467_020_17991_y
crossref_primary_10_1016_j_humimm_2012_10_003
crossref_primary_10_1016_j_ccell_2023_08_014
crossref_primary_10_1111_tan_12898
crossref_primary_10_3389_fimmu_2023_1237782
crossref_primary_10_1007_s00262_020_02749_8
crossref_primary_10_1038_s41409_022_01579_9
crossref_primary_10_3389_fimmu_2023_1269012
crossref_primary_10_1182_blood_2011_04_350868
crossref_primary_10_1111_tan_12770
crossref_primary_10_1016_j_omtn_2024_102225
crossref_primary_10_1038_leu_2014_314
crossref_primary_10_3390_cancers13133170
crossref_primary_10_3390_jcm11010253
crossref_primary_10_1111_bjh_18863
crossref_primary_10_1038_bmt_2012_267
crossref_primary_10_1182_blood_2010_04_283119
crossref_primary_10_3390_diseases13010019
crossref_primary_10_1038_leu_2016_144
crossref_primary_10_3389_fimmu_2021_659595
crossref_primary_10_1038_s41467_023_38113_4
crossref_primary_10_3389_fonc_2019_01217
crossref_primary_10_1002_stem_1140
crossref_primary_10_3389_fgene_2023_1063227
crossref_primary_10_1056_NEJMoa2030391
crossref_primary_10_1126_scitranslmed_aap9630
crossref_primary_10_3389_fimmu_2025_1603188
crossref_primary_10_1111_bjh_12197
crossref_primary_10_1182_bloodadvances_2024012798
crossref_primary_10_1016_j_advenzreg_2009_10_030
crossref_primary_10_1016_j_exphem_2016_05_013
crossref_primary_10_1007_s12032_022_01911_9
crossref_primary_10_1111_tan_12313
crossref_primary_10_1007_s12185_016_2168_y
crossref_primary_10_1111_tan_13640
crossref_primary_10_1186_s13287_021_02420_8
crossref_primary_10_1016_j_jmoldx_2014_04_003
crossref_primary_10_1080_14737140_2019_1589374
crossref_primary_10_1007_s11899_016_0330_5
crossref_primary_10_1016_j_blre_2023_101093
crossref_primary_10_1002_ijc_27661
crossref_primary_10_1186_s40364_025_00817_8
crossref_primary_10_1016_j_trim_2022_101602
crossref_primary_10_1111_j_1399_0039_2011_01799_x
crossref_primary_10_3390_ijms21218000
crossref_primary_10_1016_j_bbmt_2010_02_018
crossref_primary_10_1182_blood_2016_01_636381
crossref_primary_10_1097_MPH_0000000000000937
crossref_primary_10_1182_blood_2017_07_795062
crossref_primary_10_3390_medsci1010037
crossref_primary_10_1038_s41598_025_05602_z
crossref_primary_10_1182_bloodadvances_2025015938
crossref_primary_10_1182_blood_2019003566
crossref_primary_10_1053_j_seminhematol_2016_10_002
crossref_primary_10_1002_pd_4097
crossref_primary_10_1016_j_bbmt_2012_05_010
crossref_primary_10_3390_ijms20010228
crossref_primary_10_24287_1726_1708_2023_22_2_44_53
crossref_primary_10_1182_blood_2012_02_411686
crossref_primary_10_3109_10428194_2016_1167204
crossref_primary_10_1084_jem_20140410
crossref_primary_10_1177_09636897221102902
Cites_doi 10.1007/s10875-007-9166-z
10.1093/jnci/88.2.100
10.1002/1097-0215(20010101)91:1<109::AID-IJC1017>3.0.CO;2-E
10.1038/nri2200
10.1097/MOH.0b013e3282ef615a
10.1182/blood-2006-02-001909
10.1016/j.bbmt.2008.08.014
10.1038/ni1102-999
10.1016/S0065-230X(01)83005-0
10.1016/j.bcmd.2004.08.012
10.1158/0008-5472.CAN-08-2754
10.1200/JCO.2005.09.117
10.1007/s00281-008-0136-1
10.1111/j.1349-7006.2006.00356.x
10.1002/ijc.11241
10.1002/gcc.20234
10.1182/blood-2007-07-103325
10.1126/science.1068440
10.1016/j.humimm.2006.03.012
10.1053/j.seminhematol.2005.01.008
10.1182/blood-2008-02-140095
10.1016/j.bbmt.2007.08.003
10.1182/blood-2008-03-077974
10.1016/S0167-5699(00)01692-3
10.1016/S1470-2045(09)70074-9
10.1038/nri999
10.1158/0008-5472.375.65.2
10.1038/leu.2008.98
10.1056/NEJM199810223391702
10.1016/j.it.2008.02.005
ContentType Journal Article
Copyright Copyright © 2009 Massachusetts Medical Society. All rights reserved.
2009 INIST-CNRS
2009 Massachusetts Medical Society
Copyright_xml – notice: Copyright © 2009 Massachusetts Medical Society. All rights reserved.
– notice: 2009 INIST-CNRS
– notice: 2009 Massachusetts Medical Society
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7RV
7X7
7XB
8AO
8C1
8FE
8FH
8FI
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K0Y
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
DOI 10.1056/NEJMoa0811036
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nursing & Allied Health Database
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
Public Health Database (ProQuest)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
New England Journal of Medicine
Biological Sciences
Consumer Health Database
Healthcare Administration Database
Medical Database
Psychology Database (ProQuest)
Research Library
Science Database
Biological Science Database (ProQuest)
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
elibrary
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
New England Journal of Medicine
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
ProQuest One Psychology
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7RV
  name: ProQuest Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1533-4406
EndPage 488
ExternalDocumentID 1811092041
19641204
21804290
10_1056_NEJMoa0811036
NJ200907303610509
Genre Original Article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Telethon
  grantid: GGP08201
GroupedDBID -
0R
0WA
123
186
1AW
1KJ
1VV
29N
2KS
2WC
34G
39C
3O-
3V.
4
4.4
53G
55
5D0
5RE
68V
7FN
7RV
7X7
85S
8AO
8C1
8FE
8FH
8FI
8RP
AACLI
AAEJM
AAIKC
AALRV
AAPBV
AAQQT
AARDX
AASXA
AAWTL
ABACO
ABEFU
ABEHJ
ABFLS
ABIVO
ABOCM
ABPPZ
ABPTK
ABQES
ABQIJ
ABUFD
ABUWG
ABWJO
ACDCL
ACGFS
ACGOD
ACJLH
ACNCT
ACPRK
ACRZS
ACVYA
ADBBV
ADCBC
AENEX
AETEA
AFDAS
AFFNX
AFKRA
AFMIJ
AGNAY
AHMBA
AHVBC
AIKQT
AJJEV
AJUXI
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
AZQEC
BBAFP
BBNVY
BCR
BCU
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C45
CJ0
CO
CS3
DCD
DU5
DWQXO
DZ
EBS
EJD
ET
EX3
F20
F5P
FD8
FM.
FYUFA
G8K
GJ
GNUQQ
GUQSH
H13
HCIFZ
HZ
IH2
J5H
K-O
K78
KM
KOO
L7B
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
MVM
N9A
NEJ
O0-
O9-
OHM
OHT
OK1
OMK
OVD
P-O
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
QJJ
RHI
RWL
RXW
S10
S6N
SJFOW
SJN
TAE
TAF
TN5
TWZ
U1N
UCV
UKR
UMD
UQL
VQA
W2G
WH7
WOQ
WOW
X
X7M
XJT
XYN
XZL
YCJ
YNT
YZZ
ZA5
ZGI
ZHY
ZKB
ZR0
ZXP
---
-DZ
-ET
-~X
.-4
.55
.CO
.GJ
0R~
36B
6TJ
AAMNW
AAYXX
ABBLC
ABCQX
ABDPE
ABDQB
ABJNI
ACKOT
ACPFK
ADRHT
ADUKH
ADXHL
AERZD
AFFHD
AGHSJ
BYPQX
CCPQU
CITATION
HF~
HMCUK
HZ~
N4W
NAPCQ
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PSYQQ
TEORI
TUQ
UKHRP
YFH
YR2
YR5
YYP
ZCA
ZVN
~KM
1CY
41~
8WZ
9M8
A6W
AAQOH
AAUTI
ACPVT
ACTDY
AFFDN
AFHKK
AFOSN
ALIPV
D0S
FA8
IQODW
LPU
MQT
NHB
QZG
SKT
UBX
WHG
XOL
YHZ
YQI
YQJ
YRY
YYQ
CGR
CUY
CVF
ECM
EIF
NPM
7XB
BEC
K0Y
PKEHL
Q9U
7X8
ID FETCH-LOGICAL-c520t-793d52b1085d5d556f1240547e5bb5bc6ccaaff57146adaa32f77476e5ee8c033
IEDL.DBID DCD
ISICitedReferencesCount 428
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000268443900008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0028-4793
1533-4406
IngestDate Sun Nov 09 09:53:16 EST 2025
Mon Oct 06 17:59:22 EDT 2025
Mon Jul 21 06:03:57 EDT 2025
Mon Jul 21 09:14:18 EDT 2025
Tue Nov 18 22:36:06 EST 2025
Sat Nov 29 06:18:03 EST 2025
Wed Nov 11 00:33:08 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Incompatibility
Medicine
HLA-System
Stem cell
Major histocompatibility system
Loss
Hematopoietic cell
Stem cell transplantation
Class I histocompatibility antigen
Tumor cell
Language English
License CC BY 4.0
2009 Massachusetts Medical Society
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c520t-793d52b1085d5d556f1240547e5bb5bc6ccaaff57146adaa32f77476e5ee8c033
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Feature-3
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://zenodo.org/record/3444067
PMID 19641204
PQID 223912699
PQPubID 40644
PageCount 11
ParticipantIDs proquest_miscellaneous_67535011
proquest_journals_223912699
pubmed_primary_19641204
pascalfrancis_primary_21804290
crossref_primary_10_1056_NEJMoa0811036
crossref_citationtrail_10_1056_NEJMoa0811036
mms_nejm_10_1056_NEJMoa0811036
ProviderPackageCode DCD
7FN
PublicationCentury 2000
PublicationDate 2009-07-30
PublicationDateYYYYMMDD 2009-07-30
PublicationDate_xml – month: 07
  year: 2009
  text: 2009-07-30
  day: 30
PublicationDecade 2000
PublicationPlace Waltham, MA
PublicationPlace_xml – name: Waltham, MA
– name: United States
– name: Boston
PublicationTitle The New England journal of medicine
PublicationTitleAlternate N Engl J Med
PublicationYear 2009
Publisher Massachusetts Medical Society
Publisher_xml – name: Massachusetts Medical Society
References r020
r021
r022
r001
r017
r018
r019
r013
r015
r016
Raghavan M (r023) 2005; 65
r031
r010
r011
r012
r030
r006
r028
r007
r029
r008
r009
r002
r024
r003
Zheng P (r014) 1999; 59
r025
r004
r026
r005
r027
19641211 - N Engl J Med. 2009 Jul 30;361(5):524-5. doi: 10.1056/NEJMe0903177.
References_xml – ident: r010
  doi: 10.1007/s10875-007-9166-z
– ident: r017
  doi: 10.1093/jnci/88.2.100
– ident: r015
  doi: 10.1002/1097-0215(20010101)91:1<109::AID-IJC1017>3.0.CO;2-E
– ident: r021
  doi: 10.1038/nri2200
– ident: r004
  doi: 10.1097/MOH.0b013e3282ef615a
– ident: r006
  doi: 10.1182/blood-2006-02-001909
– ident: r009
  doi: 10.1016/j.bbmt.2008.08.014
– ident: r018
  doi: 10.1038/ni1102-999
– ident: r012
  doi: 10.1016/S0065-230X(01)83005-0
– ident: r007
  doi: 10.1016/j.bcmd.2004.08.012
– ident: r025
  doi: 10.1158/0008-5472.CAN-08-2754
– ident: r002
  doi: 10.1200/JCO.2005.09.117
– ident: r027
  doi: 10.1007/s00281-008-0136-1
– ident: r019
  doi: 10.1111/j.1349-7006.2006.00356.x
– ident: r016
  doi: 10.1002/ijc.11241
– ident: r024
  doi: 10.1002/gcc.20234
– ident: r029
  doi: 10.1182/blood-2007-07-103325
– ident: r026
  doi: 10.1126/science.1068440
– ident: r030
  doi: 10.1016/j.humimm.2006.03.012
– volume: 59
  start-page: 3461
  year: 1999
  ident: r014
  publication-title: Cancer Res
– ident: r031
  doi: 10.1053/j.seminhematol.2005.01.008
– ident: r003
  doi: 10.1182/blood-2008-02-140095
– ident: r005
  doi: 10.1016/j.bbmt.2007.08.003
– ident: r011
  doi: 10.1182/blood-2008-03-077974
– ident: r013
  doi: 10.1016/S0167-5699(00)01692-3
– ident: r008
  doi: 10.1016/S1470-2045(09)70074-9
– ident: r028
  doi: 10.1038/nri999
– volume: 65
  start-page: 375
  year: 2005
  ident: r023
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.375.65.2
– ident: r020
  doi: 10.1038/leu.2008.98
– ident: r001
  doi: 10.1056/NEJM199810223391702
– ident: r022
  doi: 10.1016/j.it.2008.02.005
– reference: 19641211 - N Engl J Med. 2009 Jul 30;361(5):524-5. doi: 10.1056/NEJMe0903177.
SSID ssj0000149
Score 2.5024402
Snippet Five patients with acute myelogenous leukemia received hematopoietic stem-cell transplants from a haploidentical donor. They also received T cells from the...
Transplantation of hematopoietic stem cells from partially matched family donors is a promising therapy for patients who have a hematologic cancer and are at...
Background Transplantation of hematopoietic stem cells from partially matched family donors is a promising therapy for patients who have a hematologic cancer...
SourceID proquest
pubmed
pascalfrancis
crossref
mms
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 478
SubjectTerms Adult
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Bone marrow
Bone marrow, stem cells transplantation. Graft versus host reaction
Cells, Cultured
Chromosomes, Human, Pair 6
General aspects
Graft vs Leukemia Effect - genetics
Graft vs Leukemia Effect - immunology
Haplotypes
Hematopoietic Stem Cell Transplantation
Histocompatibility Testing
HLA Antigens - genetics
Humans
Leukemia, Myeloid, Acute - genetics
Leukemia, Myeloid, Acute - immunology
Leukemia, Myeloid, Acute - therapy
Lymphocytes
Major Histocompatibility Complex
Medical sciences
Mutation
Myelodysplastic Syndromes
Recurrence
Retrospective Studies
Stem cells
T-Lymphocytes - immunology
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Transplantation Chimera
Transplants & implants
SummonAdditionalLinks – databaseName: Biological Science Database (ProQuest)
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB58IV58P-ozB_FksW2adnMSFcXDKoIK3kqaB6xu29Xu-vudtNlVD-tFeik0hJAvmfnSmXwDcMzzhOEpIPSFEdqPaUfay8qRHyRGIT02qZSNiGs3vb_vvLzwB5ebU7u0yrFNbAy1qqT9R36GboyHUcL5-eDdt0WjbHDVVdCYhXkrkkCbzL2HH-pRjv26H0hOYhNd_pktNF8JdIdh0Igzf7uk2aKobYKkqHGOTFvcYjr7bLzQzco_x78Ky45-kot2vazBjC7XYfHOBdg34LKLIySVIXe9GrksIqrIbfeC9ErS1aM3XfQEacqKk8ehLvwr3e-TVh-9L9pLTOUmPN9cP13d-q7Mgi9ZFAx9nBnFotxeQ1D4sMSgz0cml2qW5yyXCYIsjGEpGlWhhKCRQc6YJppp3ZEBpVswV1al3gEimeIpzylVSLOYivE15B1NVS4pjZXx4HQ805l0GuS2FEY_a2LhLMl-AePByaT5oBXfmNbwEGHLSv1aTG3wC9FJd8hwrEsOPNgbw5a5XVxnE8w8OJp8xe1nYyqi1NWozvC8ZUOzoQfb7br4HihP4jAK4t0_e96DpTY-haY-2Ie54cdIH8CC_Bz26o_DZj1_AegJ-S8
  priority: 102
  providerName: ProQuest
Title Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
URI http://dx.doi.org/10.1056/NEJMoa0811036
https://www.ncbi.nlm.nih.gov/pubmed/19641204
https://www.proquest.com/docview/223912699
https://www.proquest.com/docview/67535011
Volume 361
WOSCitedRecordID wos000268443900008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBGY
  databaseName: New England Journal of Medicine Current
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: DCD
  dateStart: 19900101
  isFulltext: true
  titleUrlDefault: https://www.nejm.org/medical-index
  providerName: Massachusetts Medical Society
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250907
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M7P
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250907
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: 7X7
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250907
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: BENPR
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Consumer Health Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250907
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M0R
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/familyhealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Healthcare Administration Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250907
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M0T
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthmanagement
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Nursing & Allied Health Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250907
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: 7RV
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Psychology Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250907
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M2M
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/psychology
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250907
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: 8C1
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250907
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M2O
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 1533-4406
  dateEnd: 20250907
  omitProxy: false
  ssIdentifier: ssj0000149
  issn: 0028-4793
  databaseCode: M2P
  dateStart: 19800103
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED_RDaG9jO8RBsUPiCcikjiO48et27SHtlRloL5Fjj-ksiadlpa_f2cn6yioAkX6KVKc6HR38f2ci-8APooyY7gKiENppQlTmiu3WTkJo8xqpMeWK-WLuA75eJzPZmLyUCTpzww-y764nvBLiZErxsm2B_voY8L1aDgbnP1WJ6rjud2noq6Y5l-3bwWfXlU17ldI2aA2bNvGYjfP9PHm4ul_S_oMDjtKSU5aH3gOj0z9Ap6MuqT5Szgdoixkaclo3iA_RStpcjk8IfOaDM362lRzSXyrcPJtZapwYBYL0tY8X8h2Y1L9Cr5fnF8NLsOudUKoWBKtQtSBZknpthZoPFhmMY4jO-OGlSUrVYaGk9YyjhOl1FLSxCIP5JlhxuQqovQ17NXL2rwBopgWXJSUaqROTKd4GovcUF0qSlNtA_h8r9NCdXXFXXuLReHz2ywrtvQSwKfN8Ju2oMaugX00UFGbn9XOAVu22zwOWYsLs1EAx_fGLLo3symQDok4yYQI4MPmKr5SLk8ia7NcNwWuoVy6NQ7gqPWAB0FFlsZJlL79l2zHcNCmnXAGj97B3up2bd7DY_VrNW9u-9Dj0x8OZ9xjjpgP4j7sn56PJ9O-d27EUTT1eOUwGXn86nHikE_uAE867ZE
linkProvider Massachusetts Medical Society
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB5RitpeWh4tpBTwgXIiIi8n60NVUR5aRHaF1EXiFhw_pC2bBMhuET-q_7HjPBY4LDcOKJdIsaw4_jLz2TP-BmCbpSHFVYBrc82VHfgdYQ4re7YTaon0WEdCVCKucdTvdy4u2Nkc_GvPwpi0ytYmVoZaFsLske-hG2OuFzL28_rGNkWjTHC1raBRo-JU3d_hiq38cXKI0_vd846PBgdduykqYAvqOWMb8Sipl5qke4kXDTV6OOQtkaJpSlMR4pC41jRCE8Il576nkSFFoaJKdYRj9j_R4r81snomg7DnDB6pVTVsu9mwaiQ9kWLsmcL2BUf36zqVGPSDC3yTZaVJyOQlzomui2nMZruV1zv-9Mq-1yJ8bOg12a__hyWYU_kyvOs1CQQr8CvGL0IKTXrDErk6IlaSbrxPhjmJ1eRKZUNOqrLp5PdYZfaBGo1Irf8-4vUhrfwznL_ICL7AfF7kag2IoJJFLPV9iTSSygBvXdZRvkyF7wdSW7DbzmwiGo11U-pjlFSxfhomT4Bgwc60-XUtLjKr4SbCJMnVn2xmgycImnaHDM5QDseC9RYmSWOlymSKEQu2pk_RvJiYEc9VMSkTXE-a0LNrwWqNw4cXZWHgek7w9dmet-B9d9CLk_ikf7oOH-pYHLo15xvMj28nagMWxN_xsLzdrP4lApcvDcb_4xFWVA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB5RWiEu9A2BFnxoe2q0eTlZH6qKLl2BCCukthK31PFD2rJJgOyC-Gn8O8aJs8BhuXGocokUy4rtzzOfPS-ATyyPKZ4CfJdrrtwo7AsTrBy4Xqwl0mOdCNEkcU2T0ah_csKOl-Cmi4UxbpWdTGwEtayEuSPvoRpjfhAz1tPWK-J4b_j97Nw1BaSMobWrptEi5FBdX-Hprf52sIdL_TkIhj9_D_ZdW2DAFTTwpi5iU9IgNw74Eh8aa9R2yGESRfOc5iLG4XGtaYLihEvOw0AjW0piRZXqC8_chaL0f56ECGITpD7w72WusszbXl7Z9J5IN3qmyH3FURX7XpMY-k4dPiuK2jhn8hrXR7eFNRYz30YDDl_-x3P3CtYs7Sa77T55DUuqfAMrR9ax4C38SHF2SKXJ0bhGDo9IlmQ_3SXjkqRqdqqKMSdNOXXya6oKd6AmE9LmhZ_wNnirfAd_nmQE72G5rEq1AURQyRKWh6FEekllhK8-66tQ5iIMI6kd-NqtciZs7nVTAmSSNT4ANM4egMKBL_PmZ23SkUUNtxEyWan-FQsbPEDTvDtkdoaKeA5sdZDJrPSqszleHNiZf0WxY2xJvFTVrM7wnGlM0r4D6y0m736UxZEfeNHmoz3vwApiMEsPRodbsNqa6FDbeR9geXoxUx_hhbicjuuL7WZbEfj71Fi8BT5rXtI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Loss+of+mismatched+HLA+in+leukemia+after+stem-cell+transplantation&rft.jtitle=The+New+England+journal+of+medicine&rft.au=Vago%2C+Luca&rft.au=Perna%2C+Serena+Kimi&rft.au=Zanussi%2C+Monica&rft.au=Mazzi%2C+Benedetta&rft.date=2009-07-30&rft.issn=1533-4406&rft.eissn=1533-4406&rft.volume=361&rft.issue=5&rft.spage=478&rft_id=info:doi/10.1056%2FNEJMoa0811036&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-4793&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-4793&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-4793&client=summon